Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Freedman

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 31, 2012
The use of natalizumab for treatment of MS: do the risks still outweigh the gains?Mark Freedman
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Immune ablation followed by autologous hematopoietic stem cell transplantation for the treatment of poor prognosis multiple sclerosisHarold Atkins, Mark Freedman
International Journal of MS Care|January 11, 2021
Letter to the Editor: Consensus Statement on Neurofilament Proteins in Multiple Sclerosis Under Development by Consortium of Multiple Sclerosis Centers (CMSC) Expert PanelMark Freedman, Sharmilee Gnanapavan
Neurologic Clinics|January 22, 2005
Immunoablative therapy as a treatment aggressive multiple sclerosisHarold Atkins, Mark Freedman
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2016
Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - YESMark Freedman, Harold L Atkins
AIDS and Behavior|September 18, 2016
Erectile Dysfunction Medication Prescription and Condomless Intercourse in HIV-Infected Men Who have Sex with Men in the United StatesXia Lin, Christine L Mattson, Mark Freedman, et al.
Annals of Internal Medicine|February 5, 2020
Recommended Adult Immunization Schedule, United States, 2020Mark Freedman, Andrew Kroger, Paul Hunter, et al.
Journal of the Neurological Sciences|March 24, 2009
Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypesFiona Costello, William Hodge, Y Irene Pan, et al.
Lancet (London, England)|June 5, 2003
Interferons in relapsing remitting multiple sclerosisMark Freedman, John King, Joel Oger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2007
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosisMartin Duddy, Masaaki Niino, Femina Adatia, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 31, 2012
The use of natalizumab for treatment of MS: do the risks still outweigh the gains?Mark Freedman
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Immune ablation followed by autologous hematopoietic stem cell transplantation for the treatment of poor prognosis multiple sclerosisHarold Atkins, Mark Freedman
International Journal of MS Care|January 11, 2021
Letter to the Editor: Consensus Statement on Neurofilament Proteins in Multiple Sclerosis Under Development by Consortium of Multiple Sclerosis Centers (CMSC) Expert PanelMark Freedman, Sharmilee Gnanapavan
Neurologic Clinics|January 22, 2005
Immunoablative therapy as a treatment aggressive multiple sclerosisHarold Atkins, Mark Freedman
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2016
Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - YESMark Freedman, Harold L Atkins
AIDS and Behavior|September 18, 2016
Erectile Dysfunction Medication Prescription and Condomless Intercourse in HIV-Infected Men Who have Sex with Men in the United StatesXia Lin, Christine L Mattson, Mark Freedman, et al.
Annals of Internal Medicine|February 5, 2020
Recommended Adult Immunization Schedule, United States, 2020Mark Freedman, Andrew Kroger, Paul Hunter, et al.
Journal of the Neurological Sciences|March 24, 2009
Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypesFiona Costello, William Hodge, Y Irene Pan, et al.
Lancet (London, England)|June 5, 2003
Interferons in relapsing remitting multiple sclerosisMark Freedman, John King, Joel Oger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2007
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosisMartin Duddy, Masaaki Niino, Femina Adatia, et al.
Pageof 3